NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

It's true that Poly-ICLC isn't approved in this application, but it has been FDA approved in another application, you'll find it here:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174192543

This should mean that Poly-ICLC can be used off label with DCVax-L or any other disease that a Dr. wants to prescribe it for with the patients agreement. Given the trial results developed at UCLA I doubt if Drs. will have much trouble getting insurance approval to use it in combination with DCVax-L in brain cancer. Other cancers will probably require more anecdotal evidence.

Gary